The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinoma-Reference-Cited by-同舟云学术

The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinoma

Published:2006-06 Issue:5 Volume:32 Page:588-591
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Rosa D.D.,Clamp A.,Mullamitha S.,Ton N.C.,Lau S.,Byrd L.,Clayton R.,Slade R.J.,Kitchener H.C.,Shanks J.H.,Wilson G.,McVey R.,Hasan J.,Swindell R.,Jayson G.C.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference23 articles.

1. Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?;Flynn;Gynecol Cancer,2002

2. Common epithelial cancer of the ovaries (first of two parts);Richardson;N Engl J Med,1985

3. Prognostic importance of the time interval from surgery to chemotherapy in treatment of ovarian carcinoma;Sorbe;Int J Gynecol Cancer,2004

4. Relationship between time interval from primary surgery to the start of taxane-plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study;Gadducci;J Clin Oncol,2005

5. Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials;Warwick;Br J Cancer,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center;Oncology Letters;2022-03-16

2. Prognostic Impact of the Time Interval between Surgery and Postoperative Adjuvant Chemotherapy in Epithelial Carcinoma of the Ovary;Hong Kong Journal of Radiology;2021-03-25

3. Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group;Journal of Clinical Medicine;2021-03-04

4. Return to intended oncologic therapy: a potentially valuable endpoint for perioperative research in cancer patients?;British Journal of Anaesthesia;2020-05

5. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;International Journal of Gynecologic Cancer;2019-05